FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Keith Buchanan

Research Profile

Procedures

Chemicals & Drugs

Disorders

Co-author Network

Publications

TOP 3
Aine M O'Connor; Suresh Pola; Blathnaid M Ward; Davina Fillmore; Keith D Buchanan; John P Kirwan
The gastroenteroinsular response to glucose ingestion during postexercise recovery.
David F Orr; Tianbao Chen; Anders H Johnsen; Rod Chalk; Keith D Buchanan; James M Sloan; Pingfan Rao; Chris Shaw
The spectrum of endogenous human chromogranin A-derived peptides identified using a modified proteomic strategy.
Carmel M McVicar; Rodat Therese Cunningham; P Harriott; CF Johnston; Keith D Buchanan; William J Curry
Analysis of the post-translational processing of chromogranin A in rat neuroendocrine tissue employing an N-terminal site-specific antiserum.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Keith Buchanan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Aine M O'Connor; Suresh Pola; Blathnaid M Ward; Davina Fillmore; Keith D Buchanan; John P Kirwan
The gastroenteroinsular response to glucose ingestion during postexercise recovery.
American journal of physiology. Endocrinology and metabolism 2006;290(6):E1155-61.
2002: David F Orr; Tianbao Chen; Anders H Johnsen; Rod Chalk; Keith D Buchanan; James M Sloan; Pingfan Rao; Chris Shaw
The spectrum of endogenous human chromogranin A-derived peptides identified using a modified proteomic strategy.
Proteomics 2002;2(11):1586-600.
2001: Carmel M McVicar; Rodat Therese Cunningham; P Harriott; CF Johnston; Keith D Buchanan; William J Curry
Analysis of the post-translational processing of chromogranin A in rat neuroendocrine tissue employing an N-terminal site-specific antiserum.
Journal of neuroendocrinology 2001;13(7):588-95.
2001: CJ Larkin; P Watson; James M Sloan; Joy Ardill; C C Patterson; W G McCluggage; Keith D Buchanan
Gastric corpus atrophy following eradication of Helicobacter pylori.
European journal of gastroenterology & hepatology 2001;13(4):377-82.
2000: AP Heaney; William J Curry; KM Pogue; VL Armstrong; M Mirakhur; Brian Sheridan; CF Johnston; Keith D Buchanan; A Brew Atkinson
Immunohistochemical evaluation of the post-translational processing of chromogranin A in human pituitary adenomas.
Pituitary 2000;3(2):67-75.
2000: Gracey Onuoha; AM Nugent; S J Hunter; EK Alpar; David McEneaney; NP Campbell; Collin Shaw; Keith D Buchanan; D Paul Nicholls
Neuropeptide variability in man.
European journal of clinical investigation 2000;30(7):570-7.
2000: G McDowell; M Cave; AD Bainbridge; M Danton; Collin Shaw; Keith D Buchanan; John Wallwork; S Large; D Paul Nicholls
Is the secretion of atrial natriuretic peptide in man under neural control?
European heart journal 2000;21(6):498-503.
1999: Gracey Onuoha; EK Alpar; D Paul Nicholls; Keith D Buchanan
Calcitonin gene-related peptide, neuropeptide Y and atrial natriuretic peptide distribution in guinea pig heart from paraffin wax-embedded and formalin-cryoprotected tissues.
The Histochemical journal 1999;31(9):617-21.
1999: S V Jassel; Joy Ardill; Davina Fillmore; K B Bamford; F A O'Connor; Keith D Buchanan
The rise in circulating gastrin with age is due to increases in gastric autoimmunity and Helicobacter pylori infection.
QJM : monthly journal of the Association of Physicians 1999;92(7):373-7.
1999: Rodat Therese Cunningham; KM Pogue; William J Curry; CF Johnston; James M Sloan; Keith D Buchanan
Immunostaining for vasostatin I distinguishes between ileal and lung carcinoids.
The Journal of pathology 1999;187(3):321-5.
1998: Joy Ardill; CJ Larkin; Davina Fillmore; Keith D Buchanan
Autoantibodies to gastrin in patients with pernicious anaemia--a novel antibody.
QJM : monthly journal of the Association of Physicians 1998;91(11):739-42.
1998: CJ Larkin; Joy Ardill; CF Johnston; J S A Collins; Keith D Buchanan
Gastrinomas and the change in their presentation and management in Northern Ireland, UK, from 1970 to 1996.
European journal of gastroenterology & hepatology 1998;10(11):947-52.
1998: DG Wang; W H Liu; CF Johnston; James M Sloan; Keith D Buchanan
Bcl-2 and c-Myc, but not bax and p53, are expressed during human medullary thyroid tumorigenesis.
The American journal of pathology 1998;152(6):1407-13.
1998: T C K Tham; L Chen; N Dennison; CF Johnston; J S A Collins; Joy Ardill; Keith D Buchanan
Effect of Helicobacter pylori eradication on antral somatostatin cell density in humans.
European journal of gastroenterology & hepatology 1998;10(4):289-91.
1998: W Shi; CF Johnston; Keith D Buchanan; W R Ferguson; JD Laird; J G Crothers; E M McIlrath
Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging.
QJM : monthly journal of the Association of Physicians 1998;91(4):295-301.
1998: DG Wang; W H Liu; F T Lundy; KM Pogue; Rodat Therese Cunningham; CF Johnston; Keith D Buchanan
TFF1 gene expression in human medullary thyroid carcinoma.
The Journal of pathology 1998;184(4):408-13.
1998: DG Wang; CF Johnston; James M Sloan; Keith D Buchanan
Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.
The Journal of pathology 1998;184(3):247-51.
1998: W Shi; Keith D Buchanan; CF Johnston; C Larkin; Y L Ong; R Ferguson; J Laird
The octreotide suppression test and [111In-DTPA-D-Phe1]-octreotide scintigraphy in neuroendocrine tumours correlate with responsiveness to somatostatin analogue treatment.
Clinical endocrinology 1998;48(3):303-9.
1997: AM Nugent; IC Steele; F al-Modaris; S Vallely; A Moore; NP Campbell; Patrick M Bell; Keith D Buchanan; E R Trimble; D Paul Nicholls
Exercise responses in patients with IDDM.
Diabetes care 1997;20(12):1814-21.
1997: DG Wang; CF Johnston; A A Barros D'Sa; Keith D Buchanan
Expression of apoptosis-suppressing gene bcl-2 in human carotid body tumours.
The Journal of pathology 1997;183(2):218-21.
1997: DG Wang; CF Johnston; Keith D Buchanan
Oncogene expression in gastroenteropancreatic neuroendocrine tumors: implications for pathogenesis.
Cancer 1997;80(4):668-75.
1997: DG Wang; CF Johnston; W H Liu; James M Sloan; Keith D Buchanan
Expression of a breast-cancer-associated protein (pS2) in human neuro-endocrine tumours.
International journal of cancer. Journal international du cancer 1997;74(3):270-4.
1997: DG Wang; CF Johnston; J J Marley; KV Phenix; A Brew Atkinson; CF Russell; Keith D Buchanan
Expression of the apoptosis-suppressing gene BCL-2 in pheochromocytoma is associated with the expression of C-MYC.
The Journal of clinical endocrinology and metabolism 1997;82(6):1949-52.
1997: G McDowell; C Shaw; Keith D Buchanan; D Paul Nicholls
Stability of plasma concentrations of N- and C-terminal atrial natriuretic peptides at room temperature.
Heart (British Cardiac Society) 1997;77(4):392.
1997: IC Steele; G McDowell; A Moore; NP Campbell; Collin Shaw; Keith D Buchanan; D Paul Nicholls
Responses of atrial natriuretic peptide and brain natriuretic peptide to exercise in patients with chronic heart failure and normal control subjects.
European journal of clinical investigation 1997;27(4):270-6.
1997: SC Barkatullah; William J Curry; CF Johnston; JC Hutton; Keith D Buchanan
Ontogenetic expression of chromogranin A and its derived peptides, WE-14 and pancreastatin, in the rat neuroendocrine system.
Histochemistry and cell biology 1997;107(3):251-7.
1997: G McDowell; W Coutie; Collin Shaw; Keith D Buchanan; A D Struthers; D Paul Nicholls
The effect of the neutral endopeptidase inhibitor drug, candoxatril, on circulating levels of two of the most potent vasoactive peptides.
British journal of clinical pharmacology 1997;43(3):329-32.
1997: F W Hanna; Joy Ardill; CF Johnston; Rodat Therese Cunningham; William J Curry; CF Russell; Keith D Buchanan
Regulatory peptides and other neuroendocrine markers in medullary carcinoma of the thyroid.
The Journal of endocrinology 1997;152(2):275-81.
1997: William J Curry; CF Johnston; C Shaw; Keith D Buchanan
Colocalization of WE-14 immunostaining with the classical islet hormones in the porcine pancreas.
Advances in experimental medicine and biology 1997;426():139-44.
1996: C M Gleeson; William J Curry; C F Johnston; Keith D Buchanan
Occurrence of WE-14 and chromogranin A-derived peptides in tissues of the human and bovine gastro-entero-pancreatic system and in human neuroendocrine neoplasia.
The Journal of endocrinology 1996;151(3):409-20.
1996: DG Wang; C F Johnston; A B Atkinson; A P Heaney; M Mirakhur; Keith D Buchanan
Expression of bcl-2 oncoprotein in pituitary tumours: comparison with c-myc.
Journal of clinical pathology 1996;49(10):795-7.
1996: DG Wang; A A Barros D'Sa; C F Johnston; Keith D Buchanan
Oncogene expression in carotid body tumors.
Cancer 1996;77(12):2581-7.
1996: Rodat Therese Cunningham; William J Curry; C F Johnston; Keith D Buchanan
Development of a radioimmunoassay to a fragment of vasostatin II.
Biochemical Society transactions 1996;24(2):304S.
1996: Keith D Buchanan; A M O'Connor; C F Johnston; Colin A Boreham
Regulatory peptides in the control of metabolism during starvation and exercise.
Biochemical Society transactions 1996;24(2):591-3.
1996: Rodat Therese Cunningham; M Watt; J Winder; S McKinstry; J T Lawson; C F Johnston; S A Hawkins; Keith D Buchanan
Serum neurone-specific enolase as an indicator of stroke volume.
European journal of clinical investigation 1996;26(4):298-303.
1996: Rodat Therese Cunningham; KM Pogue; William J Curry; C F Johnston; Keith D Buchanan
PC12 cells show immunoreactivity to a number of proteins and peptides, including vasostatin.
Peptides 1996;17(8):1297-301.
1996: D Paul Nicholls; Gracey Onuoha; G McDowell; J S Elborn; Marshall S Riley; AM Nugent; IC Steele; Collin Shaw; Keith D Buchanan
Neuroendocrine changes in chronic cardiac failure.
Basic research in cardiology 1996;91 Suppl 1():13-20.
1995: A M O'Connor; C F Johnston; Keith D Buchanan; Colin A Boreham; T R Trinick; C J Riddoch
Circulating gastrointestinal hormone changes in marathon running.
International journal of sports medicine 1995;16(5):283-7.
1995: DG Wang; C F Johnston; N Anderson; James M Sloan; Keith D Buchanan
Overexpression of the tumour suppressor gene p53 is not implicated in neuroendocrine tumour carcinogenesis.
The Journal of pathology 1995;175(4):397-401.
1994: D J Eedy; C Shaw; C F Johnston; Keith D Buchanan
The regional distribution of neuropeptides in human skin as assessed by radioimmunoassay and high-performance liquid chromatography.
Clinical and experimental dermatology 1994;19(6):463-72.
1994: Rodat Therese Cunningham; J I Morrow; C F Johnston; Keith D Buchanan
Serum neurone-specific enolase concentrations in patients with neurological disorders.
Clinica chimica acta; international journal of clinical chemistry 1994;230(2):117-24.
1994: AM Nugent; Gracey Onuoha; David McEneaney; IC Steele; S J Hunter; K Prasanna; NP Campbell; Collin Shaw; Keith D Buchanan; D Paul Nicholls
Variable patterns of atrial natriuretic peptide secretion in man.
European journal of clinical investigation 1994;24(4):267-74.
1993: R G Hayes; C Shaw; Usha Chakravarthy; Keith D Buchanan
Tachykinin-1 gene products in porcine ocular tissues: evidence for transcriptional and post-translational regulation.
Vision research 1993;33(11):1477-80.
1993: C Shaw; K Cormican; L Thim; A G Maule; J M Sloan; Keith D Buchanan
Neuropeptide Y and neuropeptide Y 3-36: isolation from human pancreatic endocrine tumours.
Regulatory peptides 1993;45(3):387-94.
1993: N U Ekeke; C Shaw; C F Johnston; Keith D Buchanan; AH Love
The effect of different dietary fats on gastrin levels in the pyloric antrum and plasma of weaner and adult Wistar rats.
The British journal of nutrition 1993;69(1):151-7.
1992: Rodat Therese Cunningham; C F Johnston; G B Irvine; Keith D Buchanan
Serum neurone-specific enolase levels in patients with neuroendocrine and carcinoid tumours.
Clinica chimica acta; international journal of clinical chemistry 1992;212(3):123-31.
1992: M J Alam; J I Kerr; K Cormican; Keith D Buchanan
Gastric inhibitory polypeptide (GIP) response in diabetes using a highly specific antiserum.
Diabetic medicine : a journal of the British Diabetic Association 1992;9(6):542-5.
1992: R G Hayes; C Shaw; P Kitabgi; Keith D Buchanan
Different relative abundance of neurotensin and neuromedin N in bovine ocular tissues.
Regulatory peptides 1992;39(2-3):147-55.
1992: William J Curry; C Shaw; C F Johnston; L Thim; Keith D Buchanan
Isolation and primary structure of a novel chromogranin A-derived peptide, WE-14, from a human midgut carcinoid tumour.
FEBS letters 1992;301(3):319-21.
1992: William J Curry; C Shaw; C F Johnston; L Thim; Keith D Buchanan
Neuropeptide F: primary structure from the tubellarian, Artioposthia triangulata.
Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology 1992;101(2):269-74.
1991: Rodat Therese Cunningham; I S Young; J Winder; M J O'Kane; S McKinstry; C F Johnston; O M Dolan; S A Hawkins; Keith D Buchanan
Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction.
European journal of clinical investigation 1991;21(5):497-500.
1991: C Shaw; R Murphy; L Thim; J B Furness; Keith D Buchanan
Marsupial possum neurotensin: a unique mammalian regulatory peptide exhibiting structural homology to the avian analogue.
Regulatory peptides 1991;35(1):49-57.
1991: D J Eedy; C Shaw; C F Johnston; E P Armstrong; Keith D Buchanan
Neuropeptides of the primary sensory neurones in rat skin: an ontogenic study.
Regulatory peptides 1991;33(2):175-82.
1991: S J McGrath-Linden; C F Johnston; Daniel O'Connor; C Shaw; Keith D Buchanan
Pancreastatin-like immunoreactivity in human carcinoid disease.
Regulatory peptides 1991;33(1):55-70.
1991: J S A Collins; Keith D Buchanan; T L Kennedy; C F Johnston; Joy Ardill; J M Sloan; E M McIlrath; C Russell
Changing patterns in presentation and management of the Zollinger-Ellison syndrome in Northern Ireland, 1970-1988.
The Quarterly journal of medicine 1991;78(287):215-25.
1991: William J Curry; C F Johnston; John C Hutton; S D Arden; N G Rutherford; C Shaw; Keith D Buchanan
The tissue distribution of rat chromogranin A-derived peptides: evidence for differential tissue processing from sequence specific antisera.
Histochemistry 1991;96(6):531-8.
1991: A A Elbadri; C Shaw; C F Johnston; D B Archer; Keith D Buchanan
The distribution of neuropeptides in the ocular tissues of several mammals: a comparative study.
Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology 1991;100(3):625-7.
1990: D M McKay; C Shaw; L Thim; C F Johnston; D W Halton; Ian Fairweather; Keith D Buchanan
The complete primary structure of pancreatic polypeptide from the European common frog, Rana temporaria.
Regulatory peptides 1990;31(3):187-97.
1990: J M McKillop; J P McCann; J R Gibbons; C F Johnston; Keith D Buchanan
Gastrin-releasing peptide in normal and neoplastic human lung: measurement and biochemical characterization.
International journal of cancer. Journal international du cancer 1990;46(4):591-61.
1990: P J Skuce; C F Johnston; Ian Fairweather; D W Halton; C Shaw; Keith D Buchanan
Immunoreactivity to the pancreatic polypeptide family in the nervous system of the adult human blood fluke, Schistosoma mansoni.
Cell and tissue research 1990;261(3):573-81.
1990: Rodat Therese Cunningham; C F Johnston; G B Irvine; E M McIlrath; A McNeill; Keith D Buchanan
Development of a radioimmunoassay for neurone specific enolase (NSE) and its application in the study of patients receiving intra hepatic arterial streptozotocin and floxuridine.
Clinica chimica acta; international journal of clinical chemistry 1990;189(3):275-86.
1990: D J Eedy; C Shaw; E P Armstrong; C F Johnston; Keith D Buchanan
Vasoactive intestinal peptide (VIP) and peptide histidine methionine (PHM) in human eccrine sweat glands: demonstration of innervation, specific binding sites and presence in secretions.
The British journal of dermatology 1990;123(1):65-76.
1990: D J Eedy; C Shaw; C F Johnston; Keith D Buchanan
Characterisation of xenopsin immunoreactivity derived from pepsinised human skin and possible mechanism of in vivo generation.
Regulatory peptides 1990;29(1):13-21.
1990: C Shaw; D McKay; C F Johnston; D W Halton; Ian Fairweather; P Kitabgi; Keith D Buchanan
Differential processing of the neurotensin/neuromedin N precursor in the mouse.
Peptides 1990;11(2):227-35.
1990: C Shaw; L Thim; C F Johnston; Keith D Buchanan
Characterisation of neurotensin-immunoreactivity in porcine ileum using region-specific radioimmunoassays and chromatographic fractionation: isolation and primary structure of porcine neurotensin.
Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology 1990;95(2):291-5.
1989: R G Peter Watson; C F Johnston; M M O'Hare; J R Anderson; B G Wilson; J S A Collins; J M Sloan; Keith D Buchanan
The frequency of gastrointestinal endocrine tumours in a well-defined population--Northern Ireland 1970-1985.
The Quarterly journal of medicine 1989;72(267):647-57.
1989: P E Armstrong; W L Foy; C F Johnston; C Shaw; R F Murphy; Keith D Buchanan
Peptide histidine isoleucine (PHI) immunoreactivity in the rat retina: identification and characterisation by radioimmunoassay, immunohistochemistry and high-performance liquid chromatography.
Regulatory peptides 1989;25(3):325-32.
1988: C F Johnston; C Shaw; Joy Ardill; J M Sloan; Keith D Buchanan
Xenopsin immunoreactivity in antral G-cells may reside in the N-terminus of gastrin 17.
Histochemistry 1988;90(2):161-4.
1986: Keith D Buchanan; C F Johnston; M M O'Hare; Joy Ardill; C Shaw; J S A Collins; R G Peter Watson; A B Atkinson; D R Hadden; T L Kennedy
Neuroendocrine tumors. A European view.
The American journal of medicine 1986;81(6B):14-22.
1985: M M O'Hare; I Huda; J M Sloan; T L Kennedy; Keith D Buchanan
Characterization of immunoreactive forms of pancreatic polypeptide in islet cell tumors using antisera with different regional specificities.
Cancer 1985;55(9):1895-8.